Literature DB >> 1531649

Adenosine phosphorothioates (ATP alpha S and ATP tau S) differentially affect the two steps of mammalian pre-mRNA splicing.

J Tazi1, M C Daugeron, G Cathala, C Brunel, P Jeanteur.   

Abstract

We have investigated the function of ATP hydrolysis in mammalian pre-mRNA in vitro splicing using adenosine phosphorothioates (ATP alpha S and ATP tau S) known to affect the activity of a number of ATP-requiring enzymes. Spliceosome assembly, but neither one of the two transesterification reactions involved in splicing, occurs with ATP alpha S suggesting that at least two types of ATP-requiring factors are brought into play. ATP alpha S has no effect in the presence of normal ATP and, therefore, spliceosomes assembled in the presence of ATP alpha S remain competent for splicing when supplied with normal ATP. ATP tau S noticeably and irreversibly inhibits the second transesterification reaction, i.e. at a time when most of the analog has been hydrolyzed and regenerated to normal ATP by creatine phosphate. This indicates that the inhibition results from an earlier event, most likely the thiophosphorylation of spliceosomal proteins. Under this assumption, the inhibition could be due to the failure of the thiophosphorylated proteins to be dephosphorylated. Indeed, okadaic acid, a potent inhibitor of protein phosphatases, inhibits the second step of a reaction in the presence of normal ATP. We propose that some splicing factors undergo phosphorylation-dephosphorylation cycles during spliceosome assembly and splicing, while others that could be the mammalian equivalents of the RNA helicase-like proteins recently discovered in yeast most likely bind and hydrolyze ATP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531649

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.

Authors:  P Ajuh; B Kuster; K Panov; J C Zomerdijk; M Mann; A I Lamond
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

2.  The ATP requirement for U2 snRNP addition is linked to the pre-mRNA region 5' to the branch site.

Authors:  C M Newnham; C C Query
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

3.  Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing.

Authors:  J E Mermoud; P Cohen; A I Lamond
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

4.  Multiple roles for SR proteins in trans splicing.

Authors:  Suzanne Furuyama; James P Bruzik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  Spliceosome assembly pathways for different types of alternative splicing converge during commitment to splice site pairing in the A complex.

Authors:  Matthew V Kotlajich; Tara L Crabb; Klemens J Hertel
Journal:  Mol Cell Biol       Date:  2008-12-08       Impact factor: 4.272

6.  Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells.

Authors:  W Seghezzi; K Chua; F Shanahan; O Gozani; R Reed; E Lees
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

7.  Detection of a novel ATP-dependent cross-linked protein at the 5' splice site-U1 small nuclear RNA duplex by methylene blue-mediated photo-cross-linking.

Authors:  Z R Liu; B Sargueil; C W Smith
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  The type 2C Ser/Thr phosphatase PP2Cgamma is a pre-mRNA splicing factor.

Authors:  M V Murray; R Kobayashi; A R Krainer
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

9.  Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.

Authors:  S H Xiao; J L Manley
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

Review 10.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.